FDA approves 1st drug for thymidine kinase 2 deficiency, a very rare mitochondrial disease

Each year, FDA’s Center for Drug Evaluation and Research (CDER) approves a wide range of new drug products. FDA provides the scientific and regulatory advice needed to bring safe, effective, high-quality generic alternatives to market, which in turn creates more affordable treatment options for pati

Unapproved New Drugs/Misbranded/Botox

Interstate Commerce/Food/Adulterated

CGMP/Finished Pharmaceuticals/Adulterated

The Food and Drug Administration is advising consumers not to purchase or use Boner Bears Chocolate, a product promoted and sold for sexual enhancement on various websites, including lockoutsupplements.com, and possibly in some retail stores.

Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet